Ovation Science Inc.
OVAT
CNSX
| 03/31/2025 | 12/31/2024 | ||||
|---|---|---|---|---|---|
| Revenue | 6.09% | 8.49% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 6.09% | 8.49% | |||
| Cost of Revenue | -86.96% | 15.00% | |||
| Gross Profit | 29.35% | 6.98% | |||
| SG&A Expenses | 26.90% | -24.08% | |||
| Depreciation & Amortization | -- | -100.00% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 21.65% | -22.84% | |||
| Operating Income | -24.63% | 26.89% | |||
| Income Before Tax | -350.53% | 85.60% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -350.53% | 85.60% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -350.53% | 85.60% | |||
| EBIT | -24.63% | 26.89% | |||
| EBITDA | -24.79% | 27.02% | |||
| EPS Basic | -380.00% | 86.49% | |||
| Normalized Basic EPS | -400.00% | 86.96% | |||
| EPS Diluted | -380.00% | 86.49% | |||
| Normalized Diluted EPS | -400.00% | 86.96% | |||
| Average Basic Shares Outstanding | -0.75% | 0.01% | |||
| Average Diluted Shares Outstanding | -0.75% | 0.01% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||